Ilaria Maggio

Via Albertoni-15
Bologna, 40138, Italy

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 27 publications

The Potential Role of Adjuvant Chemoradiotherapy in Patients with Microscopically Positive (R1) Surgical Margins after Resection of Cholangiocarcinoma.

The Potential Role of Adjuvant Chemoradiotherapy in Patients with Microscopically Positive (R1) Surgical Margins after Resection of Cholangiocarcinoma.

Journal: Current oncology (Toronto, Ont.)

Published: March 14, 2023

Engineered CAR-T and novel CAR-based therapies to fight the immune evasion of glioblastoma: gutta cavat lapidem.

Engineered CAR-T and novel CAR-based therapies to fight the immune evasion of glioblastoma: gutta cavat lapidem.

Journal: Expert review of anticancer therapy

Published: November 04, 2021

Clinical and Molecular Features of Patients with Gliomas Harboring IDH1 Non-canonical Mutations: A Systematic Review and Meta-Analysis.

Clinical and Molecular Features of Patients with Gliomas Harboring IDH1 Non-canonical Mutations: A Systematic Review and Meta-Analysis.

Journal: Advances in therapy

Published: October 02, 2021

Radiomics, mirnomics, and radiomirRNomics in glioblastoma: defining tumor biology from shadow to light.

Radiomics, mirnomics, and radiomirRNomics in glioblastoma: defining tumor biology from shadow to light.

Journal: Expert review of anticancer therapy

Published: August 26, 2021

Immune-checkpoint inhibitors in pituitary malignancies.

Immune-checkpoint inhibitors in pituitary malignancies.

Journal: Anti-cancer drugs

Published: August 04, 2021

Is Molecular Tailored-Therapy Changing the Paradigm for CNS Metastases in Breast Cancer?

Is Molecular Tailored-Therapy Changing the Paradigm for CNS Metastases in Breast Cancer?

Journal: Clinical drug investigation

Published: July 25, 2021

Discovering the Molecular Landscape of Meningioma: The Struggle to Find New Therapeutic Targets.

Discovering the Molecular Landscape of Meningioma: The Struggle to Find New Therapeutic Targets.

Journal: Diagnostics (Basel, Switzerland)

Published: July 24, 2021

Meningioma: not always a benign tumor. A review of advances in the treatment of meningiomas.

Meningioma: not always a benign tumor. A review of advances in the treatment of meningiomas.

Journal: CNS oncology

Published: May 21, 2021

IDH Inhibitors and Beyond: The Cornerstone of Targeted Glioma Treatment.

IDH Inhibitors and Beyond: The Cornerstone of Targeted Glioma Treatment.

Journal: Molecular diagnosis & therapy

Published: May 11, 2021

Quality of life assessment in renal cell carcinoma Phase II and III clinical trials published between 2010 and 2020: a systematic review.

Quality of life assessment in renal cell carcinoma Phase II and III clinical trials published between 2010 and 2020: a systematic review.

Journal: Future oncology (London, England)

Published: April 21, 2021

Distinct MRI pattern of "pseudoresponse" in recurrent glioblastoma multiforme treated with regorafenib: Case report and literature review.

Distinct MRI pattern of "pseudoresponse" in recurrent glioblastoma multiforme treated with regorafenib: Case report and literature review.

Journal: Clinical case reports

Published: March 14, 2021

Clinical efficacy of immune checkpoint inhibitors in patients with brain metastases.

Clinical efficacy of immune checkpoint inhibitors in patients with brain metastases.

Journal: Immunotherapy

Published: January 21, 2021

Showing 1-12 of 27

Last Updated: 09/26/2026